Second Life platform
Showing 1 - 25 of >10,000
Liver Transplant Disorder, Self Efficacy, Quality of Life Trial (Intelligent Case Manage Platform (ICMP) and self-management
Not yet recruiting
- Liver Transplant Disorder
- +2 more
- Intelligent Case Manage Platform (ICMP) and self-management program
- (no location specified)
Jul 12, 2023
Assessing the Feasibility of a Coach-led Digital Platform
Not yet recruiting
- Population
- Life Style, Healthy
- Human coach-led digital health platform
-
Dublin, IrelandRoyal College of Surgeons in Ireland, University of Medicine and
Oct 23, 2023
Breast Cancer, Prostate Cancer Trial in Thessaloniki (LifeChamps Platform HCP, LifeChamps Platform)
Recruiting
- Breast Cancer
- Prostate Cancer
- LifeChamps Platform HCP
- LifeChamps Platform
-
Thessaloniki, GreeceLaboratory of Medical Physics and Digital Innovation, AUTH
Mar 22, 2023
Pre-frail Trial in Edirne (Whole body vibration, The exercise program on flat ground without a vibration platform)
Enrolling by invitation
- Pre-frail
- Whole body vibration
- The exercise program on flat ground without a vibration platform
-
Edirne, TurkeyTrakya University Medical Faculty
Aug 14, 2023
Amyotrophic Lateral Sclerosis Trial (ABBV-CLS-7262 Dose 1, ABBV-CLS-7262 Dose 2, Matching Placebo)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- ABBV-CLS-7262 Dose 1
- +2 more
- (no location specified)
Feb 12, 2023
Long COVID Trial (Web-based platform. (My Viva Plan))
Not yet recruiting
- Long COVID
- Web-based platform. (My Viva Plan)
- (no location specified)
Jun 23, 2022
Construction of Perioperative Medical Data Platform and Its
Recruiting
- Anesthesia
- +2 more
- No intervention
-
Guangzhou, ChinaGuangdong Second Provincial General Hospital
Oct 3, 2022
Cancer, Telemonitoring, Telemedicine Trial in Santiago (Contigo Application)
Not yet recruiting
- Cancer
- +4 more
- Contigo Application
-
Santiago, ChileUC Christus Cancer Centre
Oct 10, 2023
Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per
Not yet recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +5 more
- Routine care as per site standard.
- (no location specified)
Sep 15, 2023
COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)
Not yet recruiting
- COVID-19
- Intramuscularly administered Ad5-nCoV vaccine
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
May 10, 2023
Multidimensional Aspects of QUAlity of Life After Cancer
Recruiting
- Solid Tumor
- Hematologic Cancer
- QoL & irAEs determinants
-
Pierre-Bénite, France
- +4 more
Nov 15, 2022
Gastrointestinal Cancers, Gastrointestinal Cancer Metastatic Trial in San Francisco (Electronic Patient Reported Outcomes
Not yet recruiting
- Gastrointestinal Cancers
- Gastrointestinal Cancer Metastatic
- Electronic Patient Reported Outcomes platform
- Health Related Quality of Life Surveys
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 1, 2023
Neuromed- Integrated Health Life Platform and Biobank
Recruiting
- Cardiovascular Diseases
- +3 more
-
Pozzilli, IS, ItalyIRCCS INM Neuromed, Department of Epidemiology and Prevention
Jan 11, 2022
Surgery--Complications, Patient Satisfaction, Quality of Life Trial in Montréal (Complete LeoMed application, Basic LeoMed
Recruiting
- Surgery--Complications
- +2 more
- Complete LeoMed application
- Basic LeoMed application
-
Montréal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Oct 11, 2022
Acute Respiratory Distress Syndrome Trial in China (device, behavioral, drug, other, biological, combination product, genetic)
Recruiting
- Acute Respiratory Distress Syndrome
- protective ventilation
- +13 more
-
Beijing, China
- +10 more
Dec 13, 2022
IBD, Crohn Disease, Ulcerative Colitis Trial (90Second IBD)
Not yet recruiting
- IBD
- +2 more
- 90Second IBD
- (no location specified)
Jan 6, 2023
Hemorrhagic Shock, Trauma Injury Trial (Low Titer Group O Whole Blood (LTOWB), Placebo, Tranexamic Acid (TXA))
Not yet recruiting
- Hemorrhagic Shock
- Trauma Injury
- Low Titer Group O Whole Blood (LTOWB)
- +3 more
- (no location specified)
Oct 9, 2023
Cancer, Cancer, Treatment-Related Trial in Chicago (ImmunOncoTool Condition)
Completed
- Cancer
- Cancer, Treatment-Related
- ImmunOncoTool Condition
-
Chicago, IllinoisNorthwestern University
Apr 5, 2022
Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations
Recruiting
- Esophageal Squamous Cell Carcinoma
- +3 more
- Routine care as per site standard
-
Multiple Locations, GermanyMultiple sites, Gemany
Jun 3, 2022
IBD, Anorectal Malformations, Spina Bifida Trial in Amsterdam-Zuidoost (StoMakker)
Recruiting
- Inflammatory Bowel Diseases
- +3 more
- StoMakker
-
Amsterdam-Zuidoost, Noord-Holland, NetherlandsAcademic Medical Centre
Oct 2, 2023
Life Stories of Patients MakingRequest for Euthanasia, in
Not yet recruiting
- Advanced Cancer
- free interview, and questionnaires in a second time
- (no location specified)
May 22, 2023
Osteoporosis, Osteoporotic Fractures Trial in China (No additional intervention will be administered.)
Recruiting
- Osteoporosis
- Osteoporotic Fractures
- No additional intervention will be administered.
-
Beijing, Beijing, China
- +37 more
Apr 14, 2022
Engagement, Patient, Mood, Quality of Life Trial in Athens, Atlanta (SimpleC Wellness Platform with Social Robot Interaction)
Completed
- Engagement, Patient
- +6 more
- SimpleC Wellness Platform with Social Robot Interaction
-
Athens, Georgia
- +1 more
May 3, 2022
Engagement, Patient, Quality of Life, Mood Trial in Athens, Atlanta (Behavioral Interventions, Robot Interventions)
Recruiting
- Engagement, Patient
- +7 more
- Behavioral Interventions
- Robot Interventions
-
Athens, Georgia
- +1 more
Oct 25, 2022
Cancer, Fertility Issues, Fertility Preservation Trial (Blood samples for analysis, Sperm samples for analysis, Satisfaction
Not yet recruiting
- Cancer
- +5 more
- Blood samples for analysis
- +3 more
- (no location specified)
May 22, 2023